MBRS-Based Psychoeducation in Patients With Schizophrenia
NCT ID: NCT07130227
Last Updated: 2025-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2021-03-30
2022-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effectiveness of Breathing Therapy in Patients With Schizophrenia
NCT07150507
Mindfulness Psychoeducation for Schizophrenia
NCT07310615
The Mindfulness-Based Psycho-Educational Program Focused on Emotion Regulation Strategies
NCT06926049
The Effect of Mindfulness-Based Psychoeducation Programme Given Individually to Schizophrenia Patients on Internalised Stigma and Healthy Lifestyle Behaviours
NCT06882538
Mindfulness-Based Education for Caregivers of Individuals Diagnosis With Schizophrenia
NCT07076940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Session 1: Preparatory Session
\*Meeting the patients \*Introducing the content of mindfulness-based stress reduction training \*Emphasizing the importance of regular and timely attendance at training \*Determining training dates \*Sharing individuals' experiences and expectations
Session 1: Preparatory Session
\*Meeting the patients \*Introducing the content of mindfulness-based stress reduction training \*Emphasizing the importance of regular and timely attendance at training \*Determining training dates \*Sharing individuals' experiences and expectations
Session 2: Mindfulness
\*What is mindfulness? \*Being aware of daily activities. \*Raisin meditation.
Session 2: Mindfulness
\*What is mindfulness? \*Being aware of daily activities. \*Raisin meditation.
Session 3: Our Perspectives on Ourselves and the World
\*Breathing meditation. \*Habit Breaker: Watching the Sky.
Session 3: Our Perspectives on Ourselves and the World
\*Breathing meditation. \*Habit Breaker: Watching the Sky.
Session 4: Body Scan *Body scan meditation.
\*Ten-finger gratitude practice. \*Habit Breaker: Spending some time in nature.
Session 4: Body Scan *Body scan meditation.
\*Ten-finger gratitude practice. \*Habit Breaker: Spending some time in nature.
Session 5: Recognizing Schizophrenia
\*What is schizophrenia? \*What are its symptoms? \*What does treatment involve?
Session 5: Recognizing Schizophrenia
\*What is schizophrenia? \*What are its symptoms? \*What does treatment involve?
Session 6: Mindful Movement
\*Mindfulness movement meditation practice \*
Session 6: Mindful Movement
\*Mindfulness movement meditation practice \*
Session 7: Mindful Breathing
\*Breathing meditation
Session 7: Mindful Breathing
\*Breathing meditation \*
Session 8: Treatment Evaluation
\*The importance of medication \*Things to consider when using medication \*Side effects of medication \*What is a flare-up in schizophrenia? \*What are the precursor symptoms?
Session 8: Treatment Evaluation
\*The importance of medication \*Things to consider when using medication \*Side effects of medication \*What is a flare-up in schizophrenia? \*What are the precursor symptoms?
Session 9: Mindful Thinking
\*Sounds and thoughts meditation \*Cinema activity.
Session 9: Mindful Thinking
\*Sounds and thoughts meditation \*Cinema activity.
Session 10: Coping with Anger
\*What is anger? \*What are its symptoms? \*What are the coping methods?
Session 10: Coping with Anger
\*What is anger? \*What are its symptoms? \*What are the coping methods?
Session 11: Coping with Difficult Emotions
\*Facing Difficulties meditation
Session 11: Coping with Difficult Emotions
\*Facing Difficulties meditation \*
Session 12: Mindful Communication
\*Communication \& mindful communication \*The importance of communication skills \*Fundamentals of communication, self-language practice \*Ways to prevent communication accidents
Session 12: Mindful Communication
\*Communication \& mindful communication \*The importance of communication skills \*Fundamentals of communication, self-language practice \*Ways to prevent communication accidents
Session 13: Different Connections
\*Breathing meditation. \*Habit Breaker: Thought and Emotional Play.
Session 13: Different Connections
\*Breathing meditation. \*Habit Breaker: Thought and Emotional Play.
Session 14: The Joy of the Small Things
\*Treasure Treasure Meditation \*Habit Breaker: Letter to Self.
Session 14: The Joy of Small Things
\*Treasure of Pleasure Meditation \*Habit Breaker: Letter to Self.
Session 15: Dwelling on the Past or Living in the Present?
\*Friendship-Building Meditation \*Habit Breaker: Random Acts of Kindness.
Session 15: Dwelling on the Past or Living in the Present?
\*Friendship-Building Meditation \*Habit Breaker: Random Acts of Kindness.
Session 16: Evaluation *Reinforcing What Has Been Learned.
\*Evaluating the Program. \*Obtaining Feedback.
Session 16: Evaluation
\*Reinforcing What Has Been Learned. \*Evaluating the Program. \*Obtaining Feedback.
Group 2: 2: Recognizing the Illness
\*What is schizophrenia? \*What are its symptoms? \*What does treatment involve?
Session 2: Group 2, Recognizing the Illness
\*What is Schizophrenia? \*What are its Symptoms? \*What Does Treatment Include?
Group 2: Session 3: Evaluating Treatment
\*Considerations regarding medication use \*Side effects of medication use \*Exacerbations in schizophrenia \*Premonitory symptoms.
Session 3: Group 2, Treatment Evaluation
\*Things to Consider When Using Medication \*Side Effects of Medication \*Exacerbation of Schizophrenia \*Precursor Symptoms.
Group 2: Session 4: *What is anger?
\*What are the symptoms of anger? \*What are the methods for coping with anger?
Session 4: Group 2, What is anger?
\*What are the symptoms of anger? \*What are the methods for coping with anger?
Group 2: Session 5: Communication *What is communication?
\*The importance of communication. \*Fundamentals of communication, self-language practice \*Ways to prevent communication difficulties.
Session 5: Group 2, Communication
\*What is communication? \*The importance of communication. \*Fundamentals of communication, working on "I" language. \*Ways to prevent communication difficulties.
Group 2: Session 6: What is relaxation?
What is progressive relaxation. Relaxation CD introduction
Session 6: Group 2, What is relaxation?
What is progressive relaxation? Introducing a relaxation CD
Group 2: Session 7: Relaxation
Performing the relaxation CD with patients
Session 7: Group 2, Relaxation
Practicing the relaxation CD with patients
Group 2: Session 8: Evaluation
\*Reinforcement of what has been learned. \*Evaluation of the program. \*Receiving feedback
Session 8: Group 2, Evaluation
\*Reinforcing what has been learned. \*Evaluating the program. \*Obtaining feedback
Group 2: Session 1: Preparatory Session
\*Meeting the patients \*Introducing the content of psychoeducation \*Emphasizing the importance of regular and timely attendance at training \*Determining training dates \*Sharing individuals' experiences and expectations
Session 1: Group 2, Preparation Session
\*Meeting Patients \*Introducing the Content of Psychoeducation \*Emphasizing the Importance of Regular and Timely Attendance at Training \*Determining Training Dates \*Sharing Individuals' Experiences and Expectations
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Session 1: Preparatory Session
\*Meeting the patients \*Introducing the content of mindfulness-based stress reduction training \*Emphasizing the importance of regular and timely attendance at training \*Determining training dates \*Sharing individuals' experiences and expectations
Session 2: Mindfulness
\*What is mindfulness? \*Being aware of daily activities. \*Raisin meditation.
Session 3: Our Perspectives on Ourselves and the World
\*Breathing meditation. \*Habit Breaker: Watching the Sky.
Session 4: Body Scan *Body scan meditation.
\*Ten-finger gratitude practice. \*Habit Breaker: Spending some time in nature.
Session 5: Recognizing Schizophrenia
\*What is schizophrenia? \*What are its symptoms? \*What does treatment involve?
Session 6: Mindful Movement
\*Mindfulness movement meditation practice \*
Session 7: Mindful Breathing
\*Breathing meditation \*
Session 8: Treatment Evaluation
\*The importance of medication \*Things to consider when using medication \*Side effects of medication \*What is a flare-up in schizophrenia? \*What are the precursor symptoms?
Session 9: Mindful Thinking
\*Sounds and thoughts meditation \*Cinema activity.
Session 10: Coping with Anger
\*What is anger? \*What are its symptoms? \*What are the coping methods?
Session 11: Coping with Difficult Emotions
\*Facing Difficulties meditation \*
Session 12: Mindful Communication
\*Communication \& mindful communication \*The importance of communication skills \*Fundamentals of communication, self-language practice \*Ways to prevent communication accidents
Session 13: Different Connections
\*Breathing meditation. \*Habit Breaker: Thought and Emotional Play.
Session 14: The Joy of Small Things
\*Treasure of Pleasure Meditation \*Habit Breaker: Letter to Self.
Session 15: Dwelling on the Past or Living in the Present?
\*Friendship-Building Meditation \*Habit Breaker: Random Acts of Kindness.
Session 16: Evaluation
\*Reinforcing What Has Been Learned. \*Evaluating the Program. \*Obtaining Feedback.
Session 1: Group 2, Preparation Session
\*Meeting Patients \*Introducing the Content of Psychoeducation \*Emphasizing the Importance of Regular and Timely Attendance at Training \*Determining Training Dates \*Sharing Individuals' Experiences and Expectations
Session 2: Group 2, Recognizing the Illness
\*What is Schizophrenia? \*What are its Symptoms? \*What Does Treatment Include?
Session 3: Group 2, Treatment Evaluation
\*Things to Consider When Using Medication \*Side Effects of Medication \*Exacerbation of Schizophrenia \*Precursor Symptoms.
Session 4: Group 2, What is anger?
\*What are the symptoms of anger? \*What are the methods for coping with anger?
Session 5: Group 2, Communication
\*What is communication? \*The importance of communication. \*Fundamentals of communication, working on "I" language. \*Ways to prevent communication difficulties.
Session 6: Group 2, What is relaxation?
What is progressive relaxation? Introducing a relaxation CD
Session 7: Group 2, Relaxation
Practicing the relaxation CD with patients
Session 8: Group 2, Evaluation
\*Reinforcing what has been learned. \*Evaluating the program. \*Obtaining feedback
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being diagnosed with schizophrenia
* Being between the ages of 18 and 60
* Being willing to participate in the study
* Being open to communication and cooperation
* Being in remission
Exclusion Criteria
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ataturk University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mine CENGİZ
Lecturer Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mine Cengiz lecturer doctor
Role: PRINCIPAL_INVESTIGATOR
Ataturk University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ataturk University Faculty of Nursing
Erzurum, Yakutiye, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCENGİZ5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.